CRISPR Gene Editing Market Growth Outlook Through 2024-2033

Overview and Scope

Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is a revolutionary biotechnology tool that enables precise modifications to the DNA of living organisms. This technology utilizes a natural defense mechanism found in bacteria, where sequences of DNA, known as CRISPR, are used to identify and cut specific genetic sequences. CRISPR gene editing allows for the addition, removal, or alteration of genetic material, making it a powerful technique for research, therapeutic applications, and potential treatments for genetic disorders.

Sizing and Forecast
The CRISPR gene editing market size has grown exponentially in recent years. It will grow from $1.78 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 26.9%.  The growth in the historic period can be attributed to increased demand for genome editing technologies, rise in government funding, increased cancer cases, increased  prevalence of chronic diseases, increased awareness about CRISPR technology, rise healthcare infrastructure.

The CRISPR gene editing market size is expected to see exponential growth in the next few years. It will grow to $5.92 billion in 2028 at a compound annual growth rate (CAGR) of 27.2%.  The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing emphasis on precision medicine, rising investment in CRISPR research and development, increasing geriatric population, growing prominence for the gene therapy procedures. Major trends in the forecast period include advancements in gene editing technology, expansion in the number of research studies, drug discovery and development, innovation in delivery methods,  adoption of CRISPR-edited agriculture.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Segmentation & Regional Insights
The CRISPR gene editing market covered in this report is segmented –
1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services:  Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical , Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies

North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of genetic disorders is expected to propel the growth of the CRISPR gene editing market going forward. A genetic disorder is a health problem caused by genome abnormalities, which include mutations in a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities. The prevalence of genetic disorders is increasing due to genetic mutations, aging populations, and consanguineous marriage. CRISPR gene editing significantly aids in managing genetic disorders by providing precise and targeted modifications to the DNA. Further, scientists use CRISPR to identify and correct specific mutations causing genetic disorders, restore normal function, and alleviate disease symptoms, as seen in conditions such as cystic fibrosis and sickle cell anemia. For instance, in April 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies born in the United States have Down syndrome each year, which occurs in about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the growth of the CRISPR gene editing market.

Key Industry Players
Major companies operating in the CRISPR gene editing market are  Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc. , Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited

The crispr gene editing market report table of contents includes:
1. Executive Summary

2. CRISPR Gene Editing Market Characteristics

3. CRISPR Gene Editing Market Trends And Strategies

4. CRISPR Gene Editing Market - Macro Economic Scenario

5. Global CRISPR Gene Editing Market Size and Growth

.

32. Global CRISPR Gene Editing Market Competitive Benchmarking

33. Global CRISPR Gene Editing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The CRISPR Gene Editing Market

35. CRISPR Gene Editing Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model